Event Date/Time: Jan 27, 2009 End Date/Time: Jan 28, 2009
Report as Spam


Advances in biomarker development are revolutionizing the way we study, diagnose and treat disease. However, progress in the development and use of biomarkers for diseases of the central nervous system has been limited by a number of difficulties - including inherent barriers associated with studying the brain.
Development of reliable biomarkers for brain disorders would dramatically accelerate research on the etiology, pathophysiology, disease progression and therapeutic development of many very prevalent and devastating diseases including Alzheimer's, Parkinson's, multiple sclerosis, and others.

During this 2-day meeting, international experts will gather to discuss the latest advances in biomarker technologies and biomarker development for brain disorders, as well as the logistical, regulatory and funding challenges experienced by scientists working on clinical trials for biomarkers.


Additional Information

Abstracts for Posters will be accepted for this meeting.